11C-Methionine PET as Prognostic Marker of Gliomas
NCT02518061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145
Last updated 2020-10-01
Summary
This is a retrospective study that involves the revision of clinical, instrumental and pathologic data of an estimated cohort of maximum 145 patients with glioma treated with surgery with radical intent at our center.
Conditions
Interventions
- OTHER
-
No intervention
This is a retrospective study
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Egesta Lopci, MD · Humanitas Clinical and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
NCT03739333 ·Status: UNKNOWN ·Phase: NA
-
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
NCT04044937 ·Status: COMPLETED ·Phase: PHASE2
-
Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.
NCT05081908 ·Status: UNKNOWN ·Phase: NA
-
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
NCT05775458 ·Status: RECRUITING
-
Image-Guided Stereotactic Biopsy of High Grade Gliomas
NCT00979810 ·Status: COMPLETED ·Phase: NA
-
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
NCT02300506 ·Status: COMPLETED
-
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
NCT06226519 ·Status: RECRUITING
-
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
NCT06241391 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiogenomic and Prognosis Analysis in Glioma
NCT04122521 ·Status: UNKNOWN
-
Glioma: Biomolecular Aspects
NCT05806619 ·Status: COMPLETED
-
FMISO-PET in Brain Tumors and SCS Effect
NCT01868906 ·Status: TERMINATED ·Phase: PHASE2
-
[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the Brain
NCT06148207 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy in High-grade Gliomas and Meningiomas
NCT05630664 ·Status: UNKNOWN
-
Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas
NCT06180226 ·Status: COMPLETED
-
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
NCT06474533 ·Status: RECRUITING
-
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
NCT05793021 ·Status: RECRUITING ·Phase: NA
-
18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
NCT04588454 ·Status: UNKNOWN ·Phase: NA
-
Personalized Translational Platform for Biomarker Discovery in Brain Tumors
NCT01240161 ·Status: COMPLETED
-
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
NCT02371031 ·Status: TERMINATED ·Phase: PHASE1
-
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
NCT02020720 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Predictive Factors for Survival in Aggressive Meningiomas
NCT05793034 ·Status: RECRUITING ·Phase: NA
-
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
NCT01579253 ·Status: UNKNOWN
-
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NCT07119294 ·Status: RECRUITING ·Phase: NA
-
68Ga-NOTA-RM26 PET/CT in Glioma Patients
NCT06412952 ·Status: RECRUITING ·Phase: EARLY_PHASE1